Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

NCT02749968 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT02749968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2018
Completion date
January 1, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blunt chest wall trauma, rib fracture, sternal fracture